News

Verona Pharma: Upcoming Conferences and Innovations in Health

Verona Pharma: Upcoming Conferences and Innovations in Health

Exciting Opportunities Ahead for Verona Pharma

Verona Pharma plc (NASDAQ: VRNA) recently announced a significant milestone as it prepares for its participation in a series of influential healthcare conferences taking place in March 2025. This initiative showcases the company's commitment to advancing its mission of delivering innovative solutions for chronic respiratory diseases, a sector where there is a substantial demand for effective treatments.

Upcoming Conferences in March 2025

In the upcoming month, Verona Pharma's senior management will present an overview of the company's current and future projects at two important events. The first is the TD Cowen 45th Annual Health Care Conference, scheduled for March 3, 2025. This event offers a platform for Verona Pharma to engage with investors and share insightful developments regarding their product pipeline.

TD Cowen 45th Annual Health Care Conference Details

During the TD Cowen conference, which will occur at 11:10 a.m. ET, Verona Pharma will showcase its latest advancements and position within the biopharmaceutical industry. The presentation will be accessible to investors interested in learning more about the company’s strategic direction and ongoing projects.

Leerink Partners 2025 Global Healthcare Conference

Following the TD Cowen event, Verona Pharma will also participate in the Leerink Partners 2025 Global Healthcare Conference on March 10, 2025, at 8:40 a.m. ET. This conference is another opportunity for the company to strengthen its relationships with stakeholders and articulate its strategies to address chronic respiratory conditions.

Webcast Availability

For those unable to attend in person, Verona Pharma ensures transparency and accessibility by providing a webcast of each conference presentation. Interested parties can easily access these webcasts through the Events and Presentations link found on the Investors section of Verona Pharma's official website.

Verona Pharma's Commitment to Innovation

Verona Pharma is at the forefront of developing therapies that fill the gap in treatment options for chronic respiratory diseases. With a primary focus on significant unmet medical needs, the company has made remarkable progress with its lead product, Ohtuvayre™ (ensifentrine). This groundbreaking inhaled therapy combines both bronchodilator and anti-inflammatory effects to provide comprehensive care for patients suffering from Chronic Obstructive Pulmonary Disease (COPD).

Potential Applications for Ensifentrine

Ensifentrine's unique properties also make it a promising candidate for treating other serious respiratory conditions, including cystic fibrosis and asthma. The ability to address multiple diseases within the respiratory spectrum highlights Verona Pharma's innovative approach and dedication to providing effective solutions where they are needed most.

Contact Information for Inquiries

To facilitate further discussions or inquiries regarding their highlights and product developments, Verona Pharma encourages interested parties to reach out through the following contacts:

Verona Pharma plc

For general inquiries, please contact the company at Tel: +1-844-341-9901.

For Investor Relations

Victoria Stewart, Senior Director of Investor Relations and Communications, can be reached via email at IR@veronapharma.com.

For US Investor Enquiries

Investors can also connect with Argot Partners at Tel: +1-212-600-1902 or email verona@argotpartners.com.

For Media Inquiries

For international and US media inquiries, reach Ten Bridge Communications at Tel: +1-781-316-4424 or email tbcverona@tenbridgecommunications.com.

Frequently Asked Questions

What is Verona Pharma known for?

Verona Pharma is a biopharmaceutical company dedicated to developing innovative therapies for chronic respiratory diseases.

What are the upcoming conferences Verona Pharma will attend?

Verona Pharma will attend the TD Cowen Health Care Conference and the Leerink Partners 2025 Global Healthcare Conference in March 2025.

How can I watch Verona Pharma's conference presentations?

Webcasts of the conference presentations will be available on the Events and Presentations link on the Investors page of Verona Pharma's website.

What is Ohtuvayre™ (ensifentrine)?

Ohtuvayre™ (ensifentrine) is an inhaled therapy for maintaining COPD treatment, combining dual actions of bronchodilation and anti-inflammation.

How can I contact Verona Pharma for investor inquiries?

You can contact Victoria Stewart, the Senior Director of Investor Relations, at IR@veronapharma.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Doughy Reinvents Cookie Dough with Bold New Identity

Updated Category News Views 346

A Gourmet Transformation: Doughy's New Identity Cookie dough isn't just for sneaking off a spoon anymore, or at least that's what Doughy aims to redefine with its innovative new identity. Launched from Kelly Ramey's brainchild in her Santa Monica kitchen, Doughy's journey from a homemade recipe to a retail sensation is nothing short of remarkable. Love it or hate it, this...

Continue Reading
Customized Anti-Aging Plans Revealed: Botox to Microneedling

Updated Category News Views 50

Intricacies of Aging: Beyond One-Size-Fits-All So you've hit a point in life where those wrinkles and sagging skin aren't just brushing off with a night's sleep. Enter Dr. Sherif Salama with his treasure trove of options fitting for the fussy nature of skin. The Aging Conundrum: Multifaceted Challenges Aging isn't a one-trick pony. Wrinkles crop up, volume disappears,...

Continue Reading
Atrium's Heart Therapies: ATR 1072's Promising Data

Updated Category News Views 103

Atrium Therapeutics Strikes a Chord with New Data Tuning into the heartbeats of breakthrough developments, Atrium Therapeutics dropped some fresh, nonclinical insights about their latest contender, ATR 1072. This wasn't just any ordinary announcement; it's like when the market hears whispers of a Fed rate adjustment. The venue? The American Heart Association's 2026...

Continue Reading
Celebree's Gratitude Push: Kindness Turns into Action

Updated Category News Views 132

Expressing Gratitude: More than Just Words Gratitude: it's one of those feel-good concepts that everyone nods to, but let's face it—most folks don't really go beyond the occasional 'thanks.' That's where the Generation Gratitude Project by Celebree School steps in. The idea's not just about saying thanks, but about making it a real, action-oriented habit. This campaign,...

Continue Reading
WaterField's Starlink Case: Compact Yet Professional

Updated Category News Views 25

Packing a Punch From Every Angle Listen, I've seen about every bag known to tech warriors, but WaterField's new Starlink Mini Go Case? It's turning some heads in the gizmo storage game. The folks at WaterField Designs, cooking out of San Francisco since '98, have whipped up something here that takes those clunky, military-style cases and swaps them for sleek, professional...

Continue Reading
Stellantis Harnesses AI for Customer Connection Boost

Updated Category News Views 135

Trading Mayhem: Pre-Market Vibes Ever put your ear to the ground on the NYSE floor and felt that buzz of untamed optimism clashing with skepticism? Today it's all about connections, from the data-driven to the familial. Imagine Stellantis (NYSE: STLA) is making a play, aligning with Amperity in an ambitious attempt to make customer interactions feel more personal. Now,...

Continue Reading
Discover Myrtle Beach's Festive Charm This Season

Updated Category News Views 52

Uniquely Coastal Celebrations in Myrtle Beach Forget the snow, friends. Picture this: you’re swapping out cozy firesides for ocean breezes this holiday season. Down in Myrtle Beach, the holidays have a bit of a coastal twist. From the vibrant Boardwalk along the oceanfront to the historic charm of riverside Conway, this area is lighting up its 14 different communities...

Continue Reading
Neurocrine Biosciences Hits $1 Billion Mark in Q3 2026

Updated Category News Views 49

Neurocrine's Triple-Digit Surge Neurocrine Biosciences is on a tear, pushing its revenue up to a jaw-dropping $1.1 billion in Q3 2026—a hefty 41% leap from the previous year. Frankly, you can't ignore those numbers. INGREZZA, which is practically becoming a cash cow, did $801 million alone, rising 17% year over year. This rides the wave of prescription surges and solid...

Continue Reading
Home Ownership in MS: Beyond Just a Mortgage

Updated Category News Views 61

Navigating the Real Costs of Homeownership in Mississippi The sunny dreams of first-time homebuyers in Mississippi often get clouded by the storm that is unforeseen expenses. You sign on the dotted line and suddenly discover that a cozy home comes with more financial baggage than just a mortgage. Steve Houck, the go-to real estate guru in Ridgeland, MS, delivers a wise...

Continue Reading
CodeBoxx CrewKit Forge: Decentralizing AI Development

Updated Category News Views 71

Unboxing the Machine: CodeBoxx's Ambitious Move When you're talking about shakin' up the tech world, look no further than CodeBoxx and their CrewKit Forge. Unveiled at the Titan 100 Tampa Bay gala, this AI software factory is a beast—a one-meter cube ready to replace a battalion of developers. Imagine not the sterile data centers but this thing chilling in your office,...

Continue Reading

Top 5 Most Recently Viewed Articles

Scientific Games Extends Key Partnership with Ohio Lottery

Updated Category News Views 145

Scientific Games Partners with Ohio Lottery for Continued Success Scientific Games is excited to announce its continued engagement with the Ohio Lottery, where it will serve as the primary provider of Scratch-Off games for the next ten years. This collaboration between the two organizations aims to foster substantial profits that will directly benefit education in the...

Continue Reading
Investing Wisely: Top Dividend Stocks to Consider Today

Updated Category News Views 140

Timing Your Investment Decisions For investors, selecting the right stocks to buy is crucial, but timing those purchases is just as important. Sometimes, being patient pays off, while at other times, quick action is essential. Currently, several stocks stand out as excellent opportunities for income investors to consider acquiring promptly. 1. National Storage Affiliates...

Continue Reading
Investors Urged to Join Class Action Against Lineage, Inc.

Updated Category News Views 99

Class Action Lawsuit Filed Against Lineage, Inc. Investors in Lineage, Inc. are facing a significant opportunity as Robbins Geller Rudman & Dowd LLP has initiated a class action lawsuit against the company. The lawsuit stems from allegations that the company's IPO in July 2024 may have misled investors regarding its financial health and future revenue streams. Financial...

Continue Reading
Earnings Insights: Midland States Bancorp Prepares for Reveal

Updated Category News Views 89

Midland States Bancorp Earnings Preview Midland States Bancorp (NASDAQ: MSBI) is preparing to release its quarterly earnings. Investors are eager to learn how the bank has been faring amidst changing economic conditions and what the future looks like for the company. With a wealth of anticipation surrounding the report, let’s delve into what to expect. Anticipated...

Continue Reading
Quanex Building Products Raises Dividend for Shareholders

Updated Category News Views 179

Quanex Building Products Announces Quarterly Dividend HOUSTON — Quanex Building Products Corporation (NX) is pleased to announce that its Board of Directors declared a quarterly cash dividend of $0.08 per share on its common stock. This dividend is scheduled to be paid to shareholders of record on a specified date, indicating the company's commitment to rewarding its...

Continue Reading